NCT05049668View on ClinicalTrials.gov

RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial

Enrolling by invitationOBSERVATIONAL
Enrollment

197

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2034

Conditions
Severe Aplastic Anemia
Interventions
DRUG

ATGAM plus CsA with or without Eltrombopag

Standard treatment with or without Eltrombopag

Trial Locations (1)

Unknown

Hospital St. Louis, Paris

All Listed Sponsors
lead

European Society for Blood and Marrow Transplantation

NETWORK